Product And Service Other — Revenue
Regeneron Pharmaceuticals Product And Service Other — Revenue decreased by 28.2% to $171.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 109.0%, from $81.90M to $171.20M. Over 4 years (FY 2021 to FY 2025), Product And Service Other — Revenue shows an upward trend with a 25.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful monetization of intellectual property or expanded partnership activity, while a decrease may indicate the conclusion of specific collaboration milestones or lower royalty income.
Detailed definition
This metric represents revenue streams generated by the company that fall outside of its primary core product franchises...
Peer comparison
Peers in the biopharmaceutical industry often report this as 'Collaboration Revenue' or 'Other Operating Income,' which varies significantly based on the stage of clinical pipelines and licensing agreements.
regn_segment_other_revenue_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.00M | $99.00M | $86.20M | $94.00M | $59.20M | $84.20M | $127.70M | $116.00M | $69.30M | $138.30M | $212.50M | $116.90M | $104.50M | $114.20M | $179.40M | $81.90M | $183.90M | $198.20M | $238.60M | $171.20M |
| QoQ Change | — | +115.2% | -12.9% | +9.0% | -37.0% | +42.2% | +51.7% | -9.2% | -40.3% | +99.6% | +53.7% | -45.0% | -10.6% | +9.3% | +57.1% | -54.3% | +124.5% | +7.8% | +20.4% | -28.2% |
| YoY Change | — | — | — | — | +28.7% | -14.9% | +48.1% | +23.4% | +17.1% | +64.3% | +66.4% | +0.8% | +50.8% | -17.4% | -15.6% | -29.9% | +76.0% | +73.6% | +33.0% | +109.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's product and service other — revenue?
- Regeneron Pharmaceuticals (REGN) reported product and service other — revenue of $171.20M in Q1 2026.
- How has Regeneron Pharmaceuticals's product and service other — revenue changed year-over-year?
- Regeneron Pharmaceuticals's product and service other — revenue increased by 109.0% year-over-year, from $81.90M to $171.20M.
- What is the long-term trend for Regeneron Pharmaceuticals's product and service other — revenue?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's product and service other — revenue has grown at a 25.7% compound annual growth rate (CAGR), from $281.20M to $702.60M.
- What does product and service other — revenue mean?
- Revenue earned from secondary sources such as partnerships, royalties, and contract services rather than primary product sales.